norethindrone has been researched along with Osteoporosis, Postmenopausal in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.33) | 18.7374 |
| 1990's | 14 (38.89) | 18.2507 |
| 2000's | 17 (47.22) | 29.6817 |
| 2010's | 2 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadji, P; Hars, O; Kalder, M; Kauka, A; Kyvernitakis, I | 1 |
| Alhava, E; Härmä, K; Honkanen, R; Jurvelin, J; Kiviniemi, V; Komulainen, M; Kröger, H; Saarikoski, S; Tuppurainen, M | 1 |
| Altekin, E; Altunyurt, S; Islekel, H; Onvural, A; Onvural, B; Posaci, C; Saygili, U | 1 |
| Jamin, C; Madelenat, P; Poncelet, C | 1 |
| Altavilla, D; Cincotta, M; Corrado, F; Crisafulli, A; D'Anna, R; Frisina, N; Gaudio, A; Ientile, R; Lasco, A; Morabito, N; Pizzoleo, MA; Squadrito, F; Vergara, C | 1 |
| Benedetti-Panici, P; Cano, A; de Villiers, T; Hillard, T; Lunde, T; Marinescu, B; Neven, P; Nickelsen, T; Peer, E; Quail, D; Tiitinen, A | 1 |
| Jirapinyo, M; Jorgensen, LN; Manonai, J; Suchartwatnachai, C; Theppisai, U | 1 |
| Eviö, S; Tiitinen, A; Välimäki, M; Ylikorkala, O | 1 |
| Birkhaeuser, MH; Bodmer, C; Fuchs, G; Kraenzlin, ME; Lippuner, K; Popp, AW; Senn, C; Wyss, H | 1 |
| Eviö, S; Furuholm, J; Meurman, JH; Sorsa, T; Tarkkila, L; Tiitinen, A; Välimäki, MJ; Ylikorkala, O | 1 |
| Başak, O; Demircan, S; Karul, A; Kizilkaya, K; Köseoğlu, K; Kozaci, LD; Odabaşi, AR; Yüksel, H | 1 |
| Boone, RH; Cheung, AM; Girlan, LM; Heathcote, EJ | 1 |
| Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Pepe, A; Vacca, F | 1 |
| Gass, R; Neff, M | 1 |
| Ellerington, MC; Hillard, TC; Lees, B; Stevenson, JC; Whitcroft, SI; Whitehead, MI | 1 |
| Horowitz, M; Morris, HA; Need, AG; Nordin, BE; Wishart, JM | 1 |
| DeCherney, A | 1 |
| Eiken, P; Kolthoff, N; Nielsen, SP | 1 |
| Cubrilo-Turek, M; Duraković, Z; Kusec, V; Stavljenić-Rukavina, A; Turek, S | 1 |
| Hermann, AP; Mosekilde, L; Orskov, H; Vestergaard, P | 1 |
| Benraad, TJ; Merkus, JM; Sweep, CG; Swinkels, LM; van der Mooren, MJ; van Hoof, HJ | 1 |
| Horowitz, M; Morris, HA; Need, AG; Nordin, BE; Scopacasa, F | 1 |
| Arce, JC; Confavreux, E; Cormier, C; de Vernejoul, MC; Delmas, PD; Fardellone, P; Garnero, P | 1 |
| Daya, S; Noyan, V; Tiraş, MB; Yildirim, M; Yildiz, A | 1 |
| Alexandersen, P; Christiansen, C; Delmas, PD; Riis, BJ; Stakkestad, JA | 1 |
| Burnet, RB; Fitzgerald, S; Nordin, BE; Schroeder, BJ; Wittert, GA | 1 |
| Chen, LH; Jorgensen, LN; Loh, FH; Yu, SL | 1 |
| Benhamou, CL; Fechtenbaum, J; Loiseau-Peres, S; Pelissier, C; Roux, C | 1 |
| Aoki, T | 1 |
| Christiansen, C; Riis, BJ | 1 |
| Frenchek, B; Speroff, L; Speroff, T; Williams, SR | 1 |
| Christiansen, C; Hartwell, D; Hassager, C; Overgaard, K; Pødenphant, JR; Riis, BJ | 1 |
| Krexner, E; Pietschmann, P; Resch, H; Willvonseder, R; Woloszczuk, W | 1 |
| Pietschmann, P; Resch, H; Willvonseder, R | 1 |
| Dören, M; Montag, M; Schneider, HP | 1 |
| Charles, P; Eriksen, EF; Hasling, C; Melsen, F; Mosekilde, L; Steiniche, T | 1 |
2 review(s) available for norethindrone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
[Tibolone].
Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hysterectomy; Lipid Metabolism; Lipids; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Rabbits; Rats; Risk Factors; Surveys and Questionnaires; Time Factors | 2002 |
Bone-sparing properties of oral contraceptives.
Topics: Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Menopause; Norethindrone; Osteoporosis, Postmenopausal; Premenopause | 1996 |
27 trial(s) available for norethindrone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Comparison of combined low-dose hormone therapy vs. tibolone in the prevention of bone loss.
Topics: Absorptiometry, Photon; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Uterine Hemorrhage | 2016 |
Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
Topics: Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Femur; Finland; Follow-Up Studies; Humans; Lumbar Vertebrae; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies | 2010 |
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Topics: Alkaline Phosphatase; Amino Acids; Bone Density; Combined Modality Therapy; Diet, Fat-Restricted; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur; Follicle Stimulating Hormone; Genistein; Humans; Isoenzymes; Lumbar Vertebrae; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoblasts; Osteocalcin; Osteoclasts; Osteoporosis, Postmenopausal; Radiography | 2002 |
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
Topics: Aged; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Progesterone Congeners; Prospective Studies; Raloxifene Hydrochloride; Single-Blind Method; Time Factors; Treatment Outcome; Uterine Diseases; Uterine Hemorrhage | 2003 |
Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Topics: Administration, Oral; Aged; Bone Density; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Progestins; Thailand; Treatment Outcome; Uterine Hemorrhage | 2003 |
Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; E-Selectin; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Sex Hormone-Binding Globulin; Time Factors | 2003 |
Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
Topics: Body Mass Index; Bone Density; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Random Allocation; Treatment Outcome | 2006 |
Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Gingival Crevicular Fluid; Humans; Longitudinal Studies; Matrix Metalloproteinase 8; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Periodontium; Placebos; Saliva; Secretory Rate | 2006 |
Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Topics: Administration, Oral; Adult; Aged; Body Composition; Body Mass Index; Body Weight; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Placebos; Postmenopause; Subcutaneous Fat, Abdominal; Waist-Hip Ratio | 2006 |
Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin.
Topics: Administration, Cutaneous; Bilirubin; Bone Density; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Treatment Outcome | 2006 |
Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
Topics: Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Postmenopause; Treatment Outcome | 2008 |
[Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate)].
Topics: Administration, Cutaneous; Bone and Bones; Bone Density; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Prospective Studies; Tomography, X-Ray Computed | 1995 |
Postmenopausal bone loss: does HRT always work?
Topics: Administration, Cutaneous; Administration, Oral; Alkaline Phosphatase; Bone Density; Calcium; Creatinine; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydroxyproline; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Osteoporosis, Postmenopausal; Phosphates; Progesterone Congeners | 1993 |
Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women.
Topics: Absorptiometry, Photon; Bone Density; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Forearm; Humans; Longitudinal Studies; Lumbar Vertebrae; Norethindrone; Osteoporosis, Postmenopausal; Progesterone Congeners | 1996 |
Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
Topics: Bone Density; Cross-Sectional Studies; Denmark; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal | 1999 |
A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women.
Topics: Aged; Biomarkers; Bone and Bones; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal | 2000 |
Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study.
Topics: Alendronate; Alkaline Phosphatase; Bone Density; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies | 2000 |
Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.
Topics: Bone Density; Calcium; Cholesterol; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Placebos; Pyrrolidines; Receptors, Estrogen; Triglycerides; Ultrasonography | 2001 |
The efficacy of two dosages of a continuous combined hormone replacement regimen.
Topics: Aged; Alkaline Phosphatase; Amino Acids; Asian People; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Collagen; Collagen Type I; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Prospective Studies; Singapore; Treatment Outcome; Triglycerides; Uterine Hemorrhage | 2002 |
Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss.
Topics: Androgen Antagonists; Bone Density; Breast; Calcium; Double-Blind Method; Estradiol; Female; Humans; Lumbar Vertebrae; Middle Aged; Norethindrone; Norpregnenes; Osteoporosis, Postmenopausal; Pain; Progesterone Congeners; Statistics, Nonparametric; Uterine Hemorrhage | 2002 |
[The preventive effect of HRT on postmenopausal bone loss].
Topics: Aged; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal | 1992 |
17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
Topics: Aged; Bone and Bones; Bone Density; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal | 1990 |
A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
Topics: Adult; Biopsy; Bone Density; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Phosphorus | 1990 |
Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.
Topics: Aged; Anabolic Agents; Calcitonin; Calcitriol; Calcium; Creatinine; Double-Blind Method; Drug Combinations; Estradiol; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Norethindrone; Osteoporosis, Postmenopausal; Patient Compliance; Phosphates; Vitamin D; Vitamin D-Binding Protein | 1990 |
Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
Topics: Aged; Bone and Bones; Calcitonin; Calcium; Estradiol; Female; Fractures, Spontaneous; Humans; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Phosphorus; Prospective Studies; Random Allocation; Spinal Injuries; Time Factors | 1989 |
[Prospective perimenopausal estrogen-progestin substitution therapies for the prevention of osteoporosis].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Prospective Studies | 1989 |
A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
Topics: Administration, Oral; Aged; Bone Density; Calcium; Drug Combinations; Estradiol; Estriol; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic | 1989 |
7 other study(ies) available for norethindrone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Alendronate; Bone Density; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Prospective Studies | 2002 |
Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcium; Creatinine; Female; Humans; Intestinal Absorption; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Parathyroid Hormone; Sodium | 1993 |
The usefulness of biochemical bone markers in predicting the response of hormone replacement therapy in perimenopausal cigarette smoking healthy women.
Topics: Alkaline Phosphatase; Biomarkers; Calcium; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Procollagen; Smoking | 1999 |
Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study.
Topics: Calcitriol; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Postmenopause | 1999 |
The effects of low dose norethisterone on biochemical variables in postmenopausal women.
Topics: Aged; Biomarkers; Bone Resorption; Calcium; Cholesterol; Drug Administration Schedule; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Phosphates; Progesterone Congeners | 1999 |
Bone densitometry in clinical practice: longitudinal measurements at three sites in postmenopausal women on five treatments.
Topics: Absorptiometry, Photon; Aged; Bone Density; Calcitriol; Calcium; Case-Control Studies; Cross-Sectional Studies; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens; Female; Femur Neck; Forearm; Humans; Longitudinal Studies; Lumbar Vertebrae; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Practice Patterns, Physicians'; Predictive Value of Tests; South Australia; Treatment Outcome | 2001 |
Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.
Topics: Alkaline Phosphatase; Bone and Bones; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Hydroxyproline; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Random Allocation; Spinal Injuries | 1990 |